DIscontinuation of Ammonul (sodium phenylacetate and sodium benzoate injection) for the treatment of hyperammomnemia

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to cmichalek@ismp.org. 

2 posts / 0 new
Log in or register to post comments
Last post
Mon, 02/24/2025 - 07:56
#1
Carol Sutherland
Carol Sutherland's picture
Offline
Last seen: 1 month 1 week ago
Joined: 09/18/2023 - 08:36
DIscontinuation of Ammonul (sodium phenylacetate and sodium benzoate injection) for the treatment of hyperammomnemia

Hi all,
We have been notified that Bausch Health US is discontinuing production of this product used for urea cycle disorders. Does anyone know whether Zydis and Foshun brands are available in the US? I am in Canada so we would have to petition Canda's version of the FDA (Health Canada) for the product to be available in Canada.
Any leads would be greatly appreciated.
Have a great day,
Carol

Top